行情

NVTR

NVTR

Nuvectra
NASDAQ

实时行情|Nasdaq Last Sale

0.1795
+0.0039
+2.22%
已收盘, 17:52 11/18 EST
开盘
0.1680
昨收
0.1756
最高
0.1950
最低
0.1650
成交量
274.47万
成交额
--
52周最高
20.85
52周最低
0.1650
市值
321.04万
市盈率(TTM)
-0.0832
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NVTR 新闻

  • 沪指低开高走 鲍威尔同特朗普及美财长会晤
  • 新浪财经.23分钟前
  • 黑田东彦大谈财政刺激效力 或淡去央行主力角色
  • 新浪财经综合.2小时前
  • 汇市或迎巨变?美元前景不妙 欧元最糟糕时期恐已过去
  • 环球外汇网官网.2小时前
  • 调查:意大利家庭主妇占11% 超38%年轻家庭为啃老族
  • 中国新闻网.2小时前

更多

所属板块

生物技术和医学研究
+0.32%
制药与医学研究
+0.13%

热门股票

名称
价格
涨跌幅

NVTR 简况

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).
展开

Webull提供Nuvectra Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。